Senesco Technologies, Inc.
1 clinical trials · Sponsor
◉ Watch Senesco Technologies, Inc.
| Record | Firm | Date |
|---|---|---|
| Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL) (NCT01435720) | Senesco Technologies, Inc. | 2011-09-01 |
Track Senesco Technologies, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.